Reuters - UnitedHealth Group Inc (UNH.N) will stick with its decision to pass on drug maker discounts to patients to help them beat rising medicine prices despite the U.S. government having withdrawn a similar proposed policy in its health programs, its top executive said on Thursday.“You can expect us not to change our stance on rebates,” Chief Executive Officer David Wichmann said on a conference call with analysts to discuss the earnings.
UnitedHealth shares were down $5.65, or 2%, at $260.94 in morning trading, after earlier rising about 1% in premarket trading on news the company beat estimates for quarterly profit and boosted its forecast for 2019 earnings...>>>
UnitedHealth shares were down $5.65, or 2%, at $260.94 in morning trading, after earlier rising about 1% in premarket trading on news the company beat estimates for quarterly profit and boosted its forecast for 2019 earnings...>>>
Nessun commento:
Posta un commento